BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30509033)

  • 1. Hydroxysafflor yellow A promotes α-synuclein clearance via regulating autophagy in rotenone-induced Parkinson's disease mice.
    Han B; Wang L; Fu F; Wang Z; Zhang L; Qi GJ; Wang T
    Folia Neuropathol; 2018; 56(2):133-140. PubMed ID: 30509033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxysafflor Yellow A Improves Motor Dysfunction in the Rotenone-Induced Mice Model of Parkinson's Disease.
    Wang T; Wang L; Li C; Han B; Wang Z; Li J; Lv Y; Wang S; Fu F
    Neurochem Res; 2017 May; 42(5):1325-1332. PubMed ID: 28097465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxysafflor yellow a protects brain microvascular endothelial cells against oxygen glucose deprivation/reoxygenation injury: Involvement of inhibiting autophagy via class I PI3K/Akt/mTOR signaling pathway.
    Yang G; Wang N; Seto SW; Chang D; Liang H
    Brain Res Bull; 2018 Jun; 140():243-257. PubMed ID: 29775658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of hydroxysafflor yellow A on dopaminergic neurons against 6-hydroxydopamine, activating anti-apoptotic and anti-neuroinflammatory pathways.
    Yang X; Li Y; Chen L; Xu M; Wu J; Zhang P; Nel D; Sun B
    Pharm Biol; 2020 Dec; 58(1):686-694. PubMed ID: 32658590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular mechanism of rotenone-induced α-synuclein aggregation: emphasizing the role of the calcium/GSK3β pathway.
    Yuan YH; Yan WF; Sun JD; Huang JY; Mu Z; Chen NH
    Toxicol Lett; 2015 Mar; 233(2):163-71. PubMed ID: 25433145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effect of hydroxysafflor yellow A on 6-hydroxydopamine-induced Parkinson's disease in rats.
    Han B; Hu J; Shen J; Gao Y; Lu Y; Wang T
    Eur J Pharmacol; 2013 Aug; 714(1-3):83-8. PubMed ID: 23791614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
    Parkhe A; Parekh P; Nalla LV; Sharma N; Sharma M; Gadepalli A; Kate A; Khairnar A
    Neurosci Lett; 2020 Jan; 716():134652. PubMed ID: 31778768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxysafflor yellow A (HSYA) alleviates apoptosis and autophagy of neural stem cells induced by heat stress via p38 MAPK/MK2/Hsp27-78 signaling pathway.
    Li H; Liu Y; Wen M; Zhao F; Zhao Z; Liu Y; Lin X; Wang L
    Biomed Pharmacother; 2019 Jun; 114():108815. PubMed ID: 30954890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxysafflor Yellow A Alleviates Ischemic Stroke in Rats via HIF-1[Formula: see text], BNIP3, and Notch1-Mediated Inhibition of Autophagy.
    Zhang Y; Liu Y; Cui Q; Fu Z; Yu H; Liu A; Liu J; Qin X; Ge S; Zhang G
    Am J Chin Med; 2022; 50(3):799-815. PubMed ID: 35300568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
    Inden M; Kitamura Y; Tamaki A; Yanagida T; Shibaike T; Yamamoto A; Takata K; Yasui H; Taira T; Ariga H; Taniguchi T
    Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in vitro model of Parkinson's disease.
    Kang SY; Lee SB; Kim HJ; Kim HT; Yang HO; Jang W
    Neurosci Lett; 2017 Mar; 642():20-26. PubMed ID: 28137648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
    Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of hydroxysafflor yellow A alone or in combination with acetylglutamine on cerebral ischemia reperfusion injury in rat: A PET study using
    Deng L; Wan H; Zhou H; Yu L; He Y
    Eur J Pharmacol; 2018 Apr; 825():119-132. PubMed ID: 29438705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxysafflor Yellow A Attenuates Lipopolysaccharide-Induced Neurotoxicity and Neuroinflammation in Primary Mesencephalic Cultures.
    Wang T; Ding YX; He J; Ma CJ; Zhao Y; Wang ZH; Han B
    Molecules; 2018 May; 23(5):. PubMed ID: 29783643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotenone impairs autophagic flux and lysosomal functions in Parkinson's disease.
    Wu F; Xu HD; Guan JJ; Hou YS; Gu JH; Zhen XC; Qin ZH
    Neuroscience; 2015 Jan; 284():900-911. PubMed ID: 25446361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxysafflor yellow A promotes apoptosis via blocking autophagic flux in liver cancer.
    Wu N; Li J; Luo H; Wang D; Bai X
    Biomed Pharmacother; 2021 Apr; 136():111227. PubMed ID: 33485070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of bcl-2 enhanced rotenone-induced α-synuclein aggregation associated with autophagic pathways.
    Chen Y; Zhang N; Ji D; Hou Y; Chen C; Fu Y; Ge R; Zheng Q; Chen J; Wang H
    Neuroreport; 2018 Sep; 29(14):1201-1208. PubMed ID: 30059366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice.
    Jin M; Wu Y; Wang L; Zang B; Tan L
    Phytother Res; 2016 Apr; 30(4):577-87. PubMed ID: 26777519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced α-synuclein and PINK1 levels after rotenone treatment.
    George S; Mok SS; Nurjono M; Ayton S; Finkelstein DI; Masters CL; Li QX; Culvenor JG
    J Mol Neurosci; 2010 Oct; 42(2):243-54. PubMed ID: 20464527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roflupram protects against rotenone-induced neurotoxicity and facilitates α-synuclein degradation in Parkinson's disease models.
    Dong WL; Zhong JH; Chen YQ; Xie JF; Qin YY; Xu JP; Cai NB; Li MF; Liu L; Wang HT
    Acta Pharmacol Sin; 2021 Dec; 42(12):1991-2003. PubMed ID: 34531546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.